← Back to Search

Psychotherapy Enhancement for Substance Use Disorders

Phase 2

Waitlist Available

Led By Samuel Ball, Ph.D.

Research Sponsored by National Institute on Drug Abuse (NIDA)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adolescent or adult substance abuser

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial will compare Dual Focus Schema Therapy to Individual Drug Counseling to see which is more effective as an enhancement to the early treatment process in a Therapeutic Community.

Who is the study for?

This trial is for adolescents and adults who use substances and can read and speak English. They must be able to provide at least two contacts. It's not suitable for individuals with mania, psychosis, or those currently experiencing acute suicidal or homicidal thoughts.Check my eligibility

What is being tested?

The study compares Dual Focus Schema Therapy with Individual Drug Counseling as enhancements during the initial phase of Therapeutic Community treatment for substance use disorders. The goal is to see which method keeps patients in therapy longer.See study design

What are the potential side effects?

Since this trial involves psychotherapy methods rather than medication, typical side effects associated with drugs are not expected. However, participants may experience emotional discomfort discussing personal issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I struggle with substance abuse.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Psychosocial functioning

Retention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)Lead Sponsor

2,465 Previous Clinical Trials

2,618,533 Total Patients Enrolled

Samuel Ball, Ph.D.Principal InvestigatorAPT Foundation, Inc.

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00086398 — Phase 2

Substance Use Disorders Research Study Groups:

Substance Use Disorders Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00086398 — Phase 2

Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00086398 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies for participants in this investigation?

"The data hosted on clinicaltrials.gov reveals that the present research trial is not actively recruiting patients, despite having been initially posted in September 2001 and last edited in November 2005. Fortunately there are 358 other studies seeking participants at this moment."

Answered by AI

Does this research study accept participants that are thirty and over?

"The criteria for entry into this medical experiment specifies that those enrolled must be between 15 and 65. Additionally, there are 75 trials specifically targeting individuals under 18 years old as well as 253 separate studies catering to patients beyond the age of retirement."

Answered by AI

What is the current federal regulatory status of this therapy?

"The safety of this intervention is estimated to be a 2 on our scale due to the presence of Phase 2 data, indicating an absence of efficacy studies but some demonstrating its security."

Answered by AI

Am I eligible to volunteer for this research initiative?

"Eligibility criteria for this trial necessitates that participants are aged between 15 and 65, and have a history of drug abuse. Our research team is looking to recruit 100 individuals in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Psychotherapy Enhancement for Therapeutic Community (TC) Retention - 1

2001. "Psychotherapy Enhancement for Therapeutic Community (TC) Retention - 1". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00086398.

All > Substance Abuse > Paid Studies Connecticut